57% of RCTs of cardiovascular nursing interventions show that they improve at least one outcome for secondary prevention patients; optimum intervention strategy unclear

2010 ◽  
Vol 13 (4) ◽  
pp. 126-127
Author(s):  
R. Gallagher
Keyword(s):  
Secondary Prevention ◽  
Intervention Strategy ◽  
Nursing Interventions ◽  
Cardiovascular Nursing

Undertaking Nursing Interventions Throughout Europe: Research Activities of the Working Group on Cardiovascular Nursing of the European Society of Cardiology

2002 ◽  
Vol 1 (3) ◽  
pp. 167-169 ◽  
Author(s):  
Keyword(s):  
Cardiac Disease ◽  
International Research ◽  
Working Group ◽  
Nursing Profession ◽  
Nursing Interventions ◽  
Coronary Risk Factors ◽  
Research Activities ◽  
International Collaborations ◽  
European Society Of Cardiology ◽  
Cardiovascular Nursing

The working Group on Cardiovascular Nursing is actively involved in international research though the UNITE (Undertaking Nursing Research Throughout Europe) research program, a new initiative for the WGCN. A group of cardiovascular nursing researchers from a number of different European countries committed themselves to a research group that is designed to promulgate international research in the field of cardiac nursing. The first study was a survey on coronary risk factors in a cohort of cardiac nurses from Europe. At this moment four additional studies are planned aimed at the development of the nursing profession in Europe and improvement of care for patients with chronic cardiac disease. If, as hoped, these studies prove to be successful, it will provide the seed for other international collaborations of this type.

scholarly journals The cost-effectiveness of the SPHERE intervention for the secondary prevention of coronary heart disease

2010 ◽  
Vol 26 (3) ◽  
pp. 263-271 ◽  
Author(s):  
Paddy Gillespie ◽  
Eamon O'Shea ◽  
Andrew W. Murphy ◽  
Mary C. Byrne ◽  
Molly Byrne ◽  
...  
Keyword(s):  
Heart Disease ◽  
Cost Effectiveness ◽  
Secondary Prevention ◽  
Intervention Strategy ◽  
Cost Savings ◽  
Decision Makers ◽  
Level Of Evidence ◽  
Care Plans ◽  
Life Years ◽  
The Cost

Objectives: The Secondary Prevention of Heart disEase in geneRal practicE (SPHERE) trial has recently reported. This study examines the cost-effectiveness of the SPHERE intervention in both healthcare systems on the island of Ireland.Methods: Incremental cost-effectiveness analysis. A probabilistic model was developed to combine within-trial and beyond-trial impacts of treatment to estimate the lifetime costs and benefits of two secondary prevention strategies: Intervention - tailored practice and patient care plans; and Control - standardized usual care.Results: The intervention strategy resulted in mean cost savings per patient of €512.77 (95 percent confidence interval [CI], −1086.46–91.98) and an increase in mean quality-adjusted life-years (QALYs) per patient of 0.0051 (95 percent CI, −0.0101–0.0200), when compared with the control strategy. The probability of the intervention being cost-effective was 94 percent if decision makers are willing to pay €45,000 per additional QALY.Conclusions: Decision makers in both settings must determine whether the level of evidence presented is sufficient to justify the adoption of the SPHERE intervention in clinical practice.

Sign in / Sign up

Export Citation Format

Share Document